| Literature DB >> 35629772 |
Hisham S M Abd-Rabboh1,2, Heba M Hashem2, Layla M S Al Shagri3, Abdel El-Galil E Amr4, Abdulrahman A Almehizia4, Ahmed M Naglah4, Ayman H Kamel2,3.
Abstract
Novel cost-effective screen-printed potentiometric platforms for simple, fast, and accurate assessment of Fluoxetine (FLX) were designed and characterized. The potentiometric platforms integrate both the FLX sensor and the reference Ag/AgCl electrode. The sensors were based on the use of 4'-nitrobenzo-15-crown-5 (ionophore I), dibenzo-18-crown-6 (ionophore II), and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD) (ionophore III) as neutral carriers within a plasticized PVC matrix. Multiwalled carbon nanotubes (MWCNTs) were used as a lipophilic ion-to-electron transducing material and sodium tetrakis [3,5-bis(trifluoromethyl)phenyl] borate (NaTFPB) was used as an anionic excluder. The presented platforms revealed near-Nernstian potentiometric response with slopes of 56.2 ± 0.8, 56.3 ± 1.7 and 64.4 ± 0.2 mV/decade and detection limits of 5.2 × 10-6, 4.7 × 10-6 and 2.0 × 10-7 M in 10 mM Tris buffer solution, pH 7 for sensors based on ionophore I, II, and III, respectively. All measurements were carried out in 10 mM tris buffer solution at pH 7.0. The interfacial capacitance before and after insertion of the MWCNTs layer was evaluated for the presented sensors using the reverse-current chronopotentiometry. The sensors were introduced for successful determination of FLX drug in different pharmaceutical dosage forms. The results were compared with those obtained by the standard HPLC method. Recovery values were calculated after spiking fixed concentrations of FLX in different serum samples. The presented platforms can be potentially manufacturable at large scales and provide a portable, rapid, disposable, and cost-effective analytical tool for measuring FLX.Entities:
Keywords: fluoxetine; multi-walled carbon nanotubes (MWCNTs); nanomaterials-based sensors; potentiometric sensors; screen printed
Year: 2022 PMID: 35629772 PMCID: PMC9144631 DOI: 10.3390/membranes12050446
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Comparison of the presented sensors with previously reported potentiometric ion-selective electrodes (ISEs).
| Sensing Material | Electrode Type | Slope, mV/DECADE | Detection Limit, M | Lower Limit of Linear | Working pH | Ref. |
|---|---|---|---|---|---|---|
| Fluoxetine/picrolonate | Liquid polymeric | 51 ± 0.5 | 6 × 10−6 | 8 × 10−6 | 1–5 | 28 |
| Fluoxetine/tetraphenylborate | Liquid polymeric | 58.5 | 2.3 × 10−5 | 4.3 × 10−5 | 4.0–7.5 | 29 |
| Coated wire graphite electrode | 55.5 | 2.5 × 10−5 | 5.4 × 10−5 | |||
| Fluoxetine/tetraphenylborate | Liquid polymeric | 51 | 3.0 × 10−6 | 3.0 × 10−6 | 4.0–7.5 | 30 |
| Fluoxetine/phosphotungstate | 51.8 | 5.0 × 10−6 | 5.0 × 10−6 | |||
| Molecular imprinting polymer (MIP), acrylamide | Solid-contact ISEs | 58.9 ± 0.2 | 2.1 × 10−6 | 1.0 × 10−5 | 10 mM acetate buffer of pH 4.5 | 31 |
| Ionophore I | Solid-contact ISEs | 56.2 ± 0.8 | 5.2 × 10−6 | 6.5 × 10−6 | 10 mM Tris buffer solution of pH 7 | This work |
| Ionophore II | 56.3 ± 1.7 | 4.7 × 10−6 | 5.6 × 10−6 | |||
| Ionophore III | 64.4 ± 0.2 | 2.0 × 10−7 | 2.0 × 10−7 |
Potentiometric response characteristic of FLX sensors in 10 mM Tris buffer, pH 7.
| Parameters | Ionophore I | Ionophore II | Ionophore III | ||||||
|---|---|---|---|---|---|---|---|---|---|
| o-NPOE | DOP | DBS | o-NPOE | DOP | DBS | o-NPOE | DOP | DBS | |
| Slope (mV/decade) | 56.2 ± 0.8 | 40.5 ± 1.2 | 40.4 ± 0.7 | 56.3 ± 1.7 | 52.2 ± 1.4 | 53.6 ± 0.3 | 64.4 ± 0.2 | 48.4 ± 0.7 | 43 ± 0.4 |
| Detection limit (M) | 5.2 × 10−6 | 6.0 × 10−6 | 1.0 × 10−5 | 4.7 × 10−6 | 6.3 × 10−6 | 2.0 × 10−5 | 2.0 × 10−7 | 8.0 × 10−7 | 3.2 × 10−6 |
| Correlation coefficient (R2) | 0.999 | 0.999 | 0.997 | 0.999 | 0.999 | 0.998 | 0.999 | 0.997 | 0.998 |
| Linear range (M) | 6.5 × 10−6–1.0 × 10−2 | 6.5 × 10−6–1.0 × 10−2 | 4.0 × 10−5–1.0 × 10−2 | 5.6 × 10−6–1.0 × 10−2 | 4.5 × 10−6–1.0 × 10−2 | 4.6 × 10−5–1.0 × 10−2 | 6.0 × 10−7–1.0 × 10−2 | 3.2 × 10−6–1.0 × 10−2 | 1.0 × 10−5–1.0 × 10−2 |
| pH range (pH) | 4.5–8.5 | 4.5–8.5 | 4.5–8.5 | 4–9 | 4–9 | 4–9 | 4–9 | 4–9 | 4–9 |
| Precision (mV %) | 1.2 | 1.4 | 1.5 | 1.3 | 1.5 | 1.2 | 1.3 | 0.9 | 1.1 |
| Accuracy (mV %) | 99.8 | 99.0 | 99.1 | 99.7 | 99.8 | 99.1 | 98.8 | 99.2 | 98.5 |
| Standard deviation (mV) | 0.5 | 0.4 | 0.6 | 0.5 | 0.8 | 0.9 | 0.4 | 0.3 | 0.7 |
Figure 1Time-trace versus FLX concentration for sensors based on (A) ionophore I (B) ionophore II; (C) ionophore III; using o-NPOE, DOP and DBS as membrane solvent mediators. (Inset: calibration plot).
Figure 2pH-potential profiles for FLX membrane sensors plasticized in o, NPOE (A) ionophore I; (B) ionophore II and (C) ionophore III.
Selectivity coefficients of both ionophore I and II membrane-based sensors plasticized in o-NPOE.
| Interfering Ion, J | |||
|---|---|---|---|
| Ionophore I | Ionophore II | Ionophore III | |
| Li+ | −5.1 ± 0.1 | −4.5 ± 0.1 | −4.8 ± 0.3 |
| Na+ | −3.7 ± 0.1 | −3.6 ± 0.2 | −4.0 ± 0.2 |
| K+ | −2.9 ± 0.3 | −2.3 ± 0.2 | −3.1 ± 0.1 |
| Rb+ | −4.0 ± 0.1 | −2.5 ± 0.1 | −3.5 ± 0.4 |
| Ca2+ | −5.1 ± 0.1 | −4.6 ± 0.1 | −4.5 ± 0.2 |
| Zn2+ | −4.7 ± 0.2 | −4.4 ± 0.3 | −4.7 ± 0.1 |
| Ba2+ | −5.3 ± 0.2 | −4.9 ± 0.2 | −4.6 ± 0.2 |
| Arginine | −5.8 ± 0.4 | −4.3 ± 0.2 | −5.6 ± 0.3 |
| Caffeine | −5.2 ± 0.1 | −4.2 ± 0.1 | −5.1 ± 0.1 |
| Glucose | −5.0 ± 0.1 | −4.4 ± 0.2 | −3.9 ± 0.3 |
| Lactose | −4.6 ± 0.2 | −3.7 ± 0.1 | −3.3 ± 0.2 |
| Paracetamol | −5.4 ± 0.3 | −3.9 ± 0.2 | −4.9 ± 0.2 |
| Norfluoxetine | −1.0 ± 0.6 | −0.7 ± 0.02 | −1.5 ± 0.1 |
* Average of 3 measurements.
Figure 3Day-to-day performance characteristics of ionophore III based sensor.
Figure 4Water layer tests for (A) non-modified, (B) and modified FLX sensors based on ionophores I, II, and III.
Figure 5Current reversal chronopotentiometry for (a) non-modified and (b) modified FLX-ISEs based on ionophores I, II, and III.
Potential drifts and double-layer capacitances for the presented sensors in the presence and absence of MWCNTs.
| Ionophore I | Ionophore II | Ionophore III | ||||
|---|---|---|---|---|---|---|
| Without MWCNTs | With MWCNTs | Without MWCNTs | With MWCNTs | Without MWCNTs | With MWCNTs | |
| Potential drift (Δ | 815.3 ± 3.4 | 95.9 ± 1.1 | 88.9 ± 1.5 | 19.4 ± 1.1 | 120.5 ± 2.1 | 24.6 ± 1.4 |
| 1.2 ± 0.7 | 10.4 ± 0.2 | 11.2 ± 2.6 | 51.5 ± 2.6 | 8.29 ± 1.3 | 40.6 ± 2.1 | |
Determination of FLX in different pharmaceutical preparations using ionophore (I) membrane-based sensor.
| Pharmaceutical | Nominal | Found, mg/Tablet | |||||
|---|---|---|---|---|---|---|---|
| Proposed Method | Mean a (%) ± SD | Reference Method, [ | Mean a (%) ± SD | ||||
| Prozac | 20 | 20.04 | 100.2 ± 0.4 | 20.1 | 100.8 ± 0.6 | 1.62 | 2.24 |
| Philozac (Amoun, Egypt) | 20 | 19.93 | 99.7 ± 0.6 | 19.8 | 99.07 ± 1.7 | 0.38 | 9.35 |
| Flutin | 20 | 20.21 | 101.0 ± 1.4 | 19.8 | 99.4 ± 0.9 | 3.69 | 2.66 |
| Depreban (Amirya, Egypt) | 20 | 19.72 | 98.6 ± 0.8 | 19.4 | 97.2 ± 0.8 | 2.13 | 1.08 |
a Mean of three replicates. b t-Student and F-test test at 95% confidence level values are 4.30 and 19.00, respectively.
Determination of FLX in different pharmaceutical preparations using ionophore (II) membrane-based sensor.
| Pharmaceutical | Nominal | Found, mg/Tablet | |||||
|---|---|---|---|---|---|---|---|
| Proposed Method | Mean a (%) ± SD | Reference Method | Mean a (%) ± SD | ||||
| Prozac | 20 | 20.9 | 102.2 ± 1.4 | 20.1 | 100.8 ± 0.6 | 2.62 | 3.24 |
| Philozac (Amoun, Egypt) | 20 | 18.9 | 99.2 ± 0.8 | 19.8 | 99.07 ± 1.7 | 1.38 | 6.87 |
| Flutin | 20 | 18.8 | 102.0 ± 1.8 | 19.8 | 99.4 ± 0.9 | 2.89 | 4.54 |
| Depreban (Amirya, Egypt) | 20 | 20.7 | 102.6 ± 1.5 | 19.4 | 97.2 ± 0.8 | 1.45 | 2.07 |
a Mean of three replicates. b t-Student and F-test test at 95% confidence level values are 4.30 and 19.00, respectively.
Determination of FLX in different pharmaceutical preparations using ionophore (II) membrane-based sensor.
| Pharmaceutical Product and Source | Nominal | Found, mg/Tablet | |||||
|---|---|---|---|---|---|---|---|
| Proposed Method | Mean a (%) ± SD | Reference Method | Mean a (%) ± SD | ||||
| Prozac | 20 | 19.7 | 98.5 ± 0.4 | 20.1 | 100.8 ± 0.6 | 2.85 | 3.12 |
| Philozac (Amoun, Egypt) | 20 | 20.9 | 104.5 ± 0.5 | 19.8 | 99.07 ± 1.7 | 3.138 | 5.24 |
| Flutin | 20 | 19.3 | 96.5 ± 0.8 | 19.8 | 99.4 ± 0.9 | 2.93 | 3.37 |
| Depreban (Amirya, Egypt) | 20 | 19.5 | 97.5 ± 0.4 | 19.4 | 97.2 ± 0.8 | 2.34 | 2.16 |
a Mean of three replicates. b t-Student and F-test test at 95% confidence level values are 4.30 and 19.00, respectively.
Potentiometric assessment of FLX in different spiked serum samples.
| Sample No. | Amount of FLX Added, μM | Ionophore I | Ionophore II | Ionophore III | |||
|---|---|---|---|---|---|---|---|
| Amount of FLX Found, μM a | Recovery, % | Amount of FLX Found, μM a | Recovery, % | Amount of FLX Found, μM a | Recovery, % | ||
| 1 | 8.0 | 7.8 ± 0.8 | 97.5 | 7.7 ± 0.9 | 96.3 | 7.8 ± 0.8 | 97.5 |
| 2 | 10.0 | 9.7 ± 0.6 | 97.0 | 9.5 ± 0.4 | 95.0 | 9.8 ± 0.4 | 98.0 |
| 3 | 15.0 | 15.5 ± 0.2 | 103.3 | 15.1 ± 0.3 | 100.6 | 14.8 ± 0.3 | 98.6 |
| 4 | 20.0 | 19.6 ± 0.7 | 98.0 | 20.1 ± 0.6 | 100.5 | 19.8 ± 0.1 | 99.0 |
a Mean of three replicates.